For over a decade, Pappas Ventures has been nurturing promising life sciences ideas and delivering superior results to investors and entrepreneurs alike.

Portfolio Highlights

• CeNeRx Biopharma completes $9 million financing
  June 15, 2009
• Bayhill Therapeutics enters exclusive, worldwide collaboration with Genentech for BHT-3021 in Type 1 diabetes
  June 10, 2009
• Tyrx presents early clinical results from AIGISRX^TM antibacterial envelope retrospective registry
  May 14, 2009

Pappas Ventures News

• BioWorld interview with Sean McCarthy
  June 15, 2009
• Sean McCarthy will participate on a panel titled "Specialty Pharma Play: Are We Near the End?" at the Bio International Convention in Atlanta, GA
  May 21, 2009
• Art Pappas will participate on a panel titled "Life Sciences Incubation Models" at the International Association of Research Parks World Conference in Raleigh, NC
  June 4, 2009